Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis

Abstract The release of inflammatory cytokines, that plays a dominant role in local pancreatic inflammation and systemic complications in severe acute pancreatitis (SAP). High-mobility group box 1 (HMGB1) is implicated in the mechanism of organ dysfunction and bacterial translocation in SAP. This cu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xia Chen, Hong-Xian Zhao, Chao Bai, Xiang-Yu Zhou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9f9a2ac66e3e499f994cd96e7fc0145f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f9a2ac66e3e499f994cd96e7fc0145f
record_format dspace
spelling oai:doaj.org-article:9f9a2ac66e3e499f994cd96e7fc0145f2021-12-02T11:52:33ZBlockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis10.1038/s41598-017-07094-y2045-2322https://doaj.org/article/9f9a2ac66e3e499f994cd96e7fc0145f2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07094-yhttps://doaj.org/toc/2045-2322Abstract The release of inflammatory cytokines, that plays a dominant role in local pancreatic inflammation and systemic complications in severe acute pancreatitis (SAP). High-mobility group box 1 (HMGB1) is implicated in the mechanism of organ dysfunction and bacterial translocation in SAP. This current study aims to investigate possible role of HMGB1 in the intestinal mucosal barrier dysfunction of SAP, and the effect of anti-HMGB1 antibody treatment in intestinal mucosal injury in SAP. Our data revealed that the HMGB1 expression was significantly increased in AP mice induced by caerulein and LPS, and the inhibition of HMGB1 played a protective role in intestinal mucosal barrier dysfunction, reduced the serum level of other proinflammatory cytokines include IL-1β, IL-6, TNF-α. Next we investigated the downstream receptors involving in HMGB1 signaling. We found that the expressions of toll-like receptor (TLR) 4 and TLR9 were elevated in ileum of AP mice, the administration of HMGB1 neutralizing antibody significantly reduced the TLR4 and TLR9 expression. It was concluded that HMGB1 contributed the mechanism to the intestinal mucosal barrier dysfunction during AP. Blockade of HMGB1 by administration of HMGB1 neutralizing antibody may be a beneficial therapeutic strategy in improving intestinal mucosal barrier dysfunction in SAP.Xia ChenHong-Xian ZhaoChao BaiXiang-Yu ZhouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xia Chen
Hong-Xian Zhao
Chao Bai
Xiang-Yu Zhou
Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
description Abstract The release of inflammatory cytokines, that plays a dominant role in local pancreatic inflammation and systemic complications in severe acute pancreatitis (SAP). High-mobility group box 1 (HMGB1) is implicated in the mechanism of organ dysfunction and bacterial translocation in SAP. This current study aims to investigate possible role of HMGB1 in the intestinal mucosal barrier dysfunction of SAP, and the effect of anti-HMGB1 antibody treatment in intestinal mucosal injury in SAP. Our data revealed that the HMGB1 expression was significantly increased in AP mice induced by caerulein and LPS, and the inhibition of HMGB1 played a protective role in intestinal mucosal barrier dysfunction, reduced the serum level of other proinflammatory cytokines include IL-1β, IL-6, TNF-α. Next we investigated the downstream receptors involving in HMGB1 signaling. We found that the expressions of toll-like receptor (TLR) 4 and TLR9 were elevated in ileum of AP mice, the administration of HMGB1 neutralizing antibody significantly reduced the TLR4 and TLR9 expression. It was concluded that HMGB1 contributed the mechanism to the intestinal mucosal barrier dysfunction during AP. Blockade of HMGB1 by administration of HMGB1 neutralizing antibody may be a beneficial therapeutic strategy in improving intestinal mucosal barrier dysfunction in SAP.
format article
author Xia Chen
Hong-Xian Zhao
Chao Bai
Xiang-Yu Zhou
author_facet Xia Chen
Hong-Xian Zhao
Chao Bai
Xiang-Yu Zhou
author_sort Xia Chen
title Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
title_short Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
title_full Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
title_fullStr Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
title_full_unstemmed Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
title_sort blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9f9a2ac66e3e499f994cd96e7fc0145f
work_keys_str_mv AT xiachen blockadeofhighmobilitygroupbox1attenuatesintestinalmucosalbarrierdysfunctioninexperimentalacutepancreatitis
AT hongxianzhao blockadeofhighmobilitygroupbox1attenuatesintestinalmucosalbarrierdysfunctioninexperimentalacutepancreatitis
AT chaobai blockadeofhighmobilitygroupbox1attenuatesintestinalmucosalbarrierdysfunctioninexperimentalacutepancreatitis
AT xiangyuzhou blockadeofhighmobilitygroupbox1attenuatesintestinalmucosalbarrierdysfunctioninexperimentalacutepancreatitis
_version_ 1718395001226919936